Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).

MLA

T’jollyn, Huybrecht, et al. “Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).” European Journal of Drug Metabolism and Pharmacokinetics, vol. 49, no. 4, July 2024, pp. 491–506. EBSCOhost, https://doi.org/10.1007/s13318-024-00899-z.

APA

T’jollyn, H., Venkatasubramanian, R., Neyens, M., Gopal, S., Russu, A., Nandy, P., Perez-Ruixo, J. J., & Ackaert, O. (2024). Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II). European Journal of Drug Metabolism and Pharmacokinetics, 49(4), 491–506. https://doi.org/10.1007/s13318-024-00899-z

Chicago

T’jollyn, Huybrecht, Raja Venkatasubramanian, Martine Neyens, Srihari Gopal, Alberto Russu, Partha Nandy, Juan Jose Perez-Ruixo, and Oliver Ackaert. 2024. “Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).” European Journal of Drug Metabolism and Pharmacokinetics 49 (4): 491–506. doi:10.1007/s13318-024-00899-z.